A new compound that kills tuberculosis bacteria by inhibiting ATP synthase at a different site than existing drugs like bedaquiline.
RT’s Three Key Takeaways:
- Novel Drug Targeting Energy Production – Researchers…
Novel Drug Candidate for Tuberculosis
